Ad
related to: what is the fdathecountyoffice.com has been visited by 1M+ users in the past month
Search results
FDA rescinds marketing ban on JUUL
Axios· 4 hours agoFood and Drug Administration rescinded a marketing ban on Juul e-cigarettes, saying Thursday that it is reviewing new case law and weighing updated...
‘Dead wrong’: Lawmakers, advocates decry rejection of MDMA-assisted therapy by FDA panel
The Hill via Yahoo News· 9 hours agoA Food and Drug Administration (FDA) panel’s surprising recommendation this week to reject the use...
Juul e-cigarettes’ FDA ban lifted
Market Watch· 10 hours agoThe move does not authorize or deny Juul’s applications but returns them to pending status, the FDA said. The decision comes after new case law was...
Some Breather For E-Cigarette Maker Juul As FDA Reconsiders Marketing Denials Issued Two Years Ago
Benzinga via AOL· 6 hours agoThe FDA has rescinded the marketing denial orders (MDOs) issued to JUUL Labs Inc., partially due to...
FDA reverses its ban on Juul vaping products
Scripps News via AOL· 4 hours agoThe U.S. Food and Drug Administration has reversed its ban on JUUL products, potentially opening the door for the brand to get its e-cigarettes and vapes...
US FDA rescinds market denial order for Juul products
Reuters via AOL· 11 hours agoThe latest move comes a few months after Juul sought an FDA authorization for new menthol-flavored...
Some Breather For E-Cigarette Maker Juul As FDA Reconsiders Marketing Denials Issued Two Years Ago
Benzinga· 6 hours agoThe FDA has rescinded the marketing denial orders (MDOs) issued to JUUL Labs Inc., partially due to...
JD Supra: Key Takeaways from FDA’s Final Rule on Laboratory-Developed Tests
JD Supra· 8 hours agoThe US Food and Drug Administration (FDA) on April 29, 2024 announced its Final Rule on laboratory-developed tests (LDTs). This marks the beginning of the end of ...
FDA panel recommends new COVID-19 vaccine formula for fall
UPI· 11 hours agoDr. Peter Marks, who oversees the FDA's vaccine division, urged the committee to consider...
FDA lays out donanemab concerns ahead of meeting, as Lilly vigorously defends safety
FierceBiotech· 11 hours agoThe docs for Eli Lilly’s donanemab advisory committee meeting are in: the FDA has raised concerns...
